Stimulus‐Responsive Nanozymes for Mitochondria‐Targeted Therapy: Design, Mechanisms, and Biomedical Applications

{"Mitochondrial":[0],"dysfunction":[1],"represents":[2],"a":[3,40,110],"common":[4],"pathological":[5,47],"hub":[6],"in":[7,142],"tumors,":[8],"neurodegenerative":[9],"diseases,":[10,12,147],"cardiovascular":[11,146],"and":[13,27,57,67,84,96,102,127,148,161,174],"inflammatory":[14,149],"degenerative":[15,150],"diseases.":[16,151],"Nanozymes":[17],"offer":[18],"new":[19],"opportunities":[20],"for":[21,53,177],"precision":[22],"intervention.":[23],"However,":[24],"inadequate":[25],"targeting":[26,87],"uncontrollable":[28],"activity":[29],"remain":[30],"major":[31,78],"obstacles":[32],"to":[33,120],"their":[34,85],"clinical":[35],"translation.":[36],"This":[37],"review":[38,135],"proposes":[39],"\\"trinity\\"":[41],"synergistic":[42,104],"design":[43,95],"paradigm,":[44],"which":[45],"exploits":[46],"mitochondrial":[48,86,121],"signals":[49],"as":[50],"dual-functional":[51],"cues":[52],"both":[54],"subcellular":[55],"navigation":[56],"catalytic":[58,118],"activation,":[59],"thereby":[60],"achieving":[61],"temporal":[62],"coupling":[63],"of":[64,80,99,139,170,180],"\\"targeting":[65],"enrichment\\"":[66],"\\"responsive":[68],"activation.\\"":[69],"Within":[70],"this":[71,131,159],"framework,":[72],"we":[73,90,133,153],"first":[74],"summarize":[75],"the":[76,93,136,155,168,178],"three":[77],"categories":[79],"nanozyme":[81],"material":[82],"systems":[83],"strategies.":[88],"Subsequently,":[89],"systematically":[91],"analyze":[92,154],"structural":[94],"activation":[97],"mechanisms":[98],"endogenous,":[100],"exogenous,":[101],"multi-stimulus":[103],"responsive":[105],"nanozymes.":[106],"We":[107],"also":[108],"establish":[109],"cross-scale":[111],"effect":[112],"chain":[113],"model":[114],"that":[115],"cascades":[116],"from":[117],"events":[119],"metabolic":[122],"remodeling,":[123],"programmed":[124],"cell":[125],"death,":[126],"immune":[128],"regulation.":[129],"On":[130],"basis,":[132],"comprehensively":[134],"therapeutic":[137],"applications":[138],"these":[140],"nanozymes":[141],"oncology,":[143],"neurological":[144],"disorders,":[145],"Finally,":[152],"critical":[156],"challenges":[157],"confronting":[158],"field":[160],"provide":[162],"perspectives":[163],"on":[164],"future":[165],"directions,":[166],"with":[167],"aim":[169],"offering":[171],"theoretical":[172],"references":[173],"research":[175],"ideas":[176],"development":[179],"mitochondria-targeted":[181],"intelligent":[182],"nanomedicines.":[183]}